Michael Hofman

Biography

Associate Professor Michael Hofman is a nuclear medicine physician in the Centre for Cancer Imaging at the Peter MacCallum Cancer in Melbourne.He has a broad interest inpositron emission tomography (PET), molecular imaging applications in oncology and radionuclide therapy. Associate Professor Hofman has a vision of improving patient outcomes by using molecular imaging to non-invasively characterise disease thereby enabling improved selection of the most appropriate therapy for an individual patient and better assessment of therapeutic response. He has particular interest in novel PET radiotracers, including F-18 and Ga-68, and theranostic applications including neuroendocrine and prostate cancers. Currently, he is the principal investigator of a randomised multi-centre trial of PSMA PET/CT in PET/CT, a prospective trial of Lu-177 PSMA therapy and a propsective trial investigating the role of PET V/Q scanning in patients with lung cancer. Associate Professor Hofman previously completed a clinical and research fellowship at Guys and St Thomas in London. He is a fellow of the Inernational Cancer Imaging Society (ICIS) and serves on the editoral board of Cancer Imaging, Leukaemia Lymphoma and the Journal of Medical Imaging and Radiation Oncology (JMIRO). He is an inaugral scientific member of the Australasian Radiopharmaceutical Trials Network (ARTnet).

Research Interest

Nuclear medicine